Shape Therapeutics

Shape Therapeutics

Biotechnology, 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States, 51-200 Employees

shapetx.com

  • twitter
  • LinkedIn

phone no Phone Number: 62********

Who is SHAPE THERAPEUTICS

ShapeTX is pioneering the field of programmable RNA medicines to repair the genetic causes of diseases. By merging innovations in AI and RNA technology to generate and analyze hundreds of...

Read More

map
  • 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Headquarters: 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States
  • 2018 Date Founded: 2018
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from SHAPE THERAPEUTICS

Shape Therapeutics Org Chart and Mapping

Employees

Rafael Ponce

EVP, Preclinical Development

Jamie Siemering

Vice President, People Operations

Stephanie Kall

Senior Research Associate

Chelsea Fortin

Scientist II, Liver and Metabolic Diseases

Nicole Enger

Senior Research Associate

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Shape Therapeutics

Answer: Shape Therapeutics's headquarters are located at 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States

Answer: Shape Therapeutics's phone number is 62********

Answer: Shape Therapeutics's official website is https://shapetx.com

Answer: Shape Therapeutics's revenue is $1 Million to $5 Million

Answer: Shape Therapeutics's SIC: 8731

Answer: Shape Therapeutics has 51-200 employees

Answer: Shape Therapeutics is in Biotechnology

Answer: Shape Therapeutics contact info: Phone number: 62******** Website: https://shapetx.com

Answer: ShapeTX is pioneering the field of programmable RNA medicines to repair the genetic causes of diseases. By merging innovations in AI and RNA technology to generate and analyze hundreds of billions of therapeutic possibilities, ShapeTX is developing breakthroughs in RNA editing, next-generation AAVs, and disruptive gene therapy manufacturing. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimers, Parkinsons, and many more.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access